Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.

International journal of clinical and experimental pathology - 1 Jan 2014

Sasaki Yuka, Sasaki Takeshi, Kawai Taketo, Morikawa Teppei, Matsusaka Keisuke, Kunita Akiko, Kume Haruki, Aoki Ichiro, Homma Yukio, Fukayama Masashi

Abstract excerpt

Upper urinary tract urothelial carcinomas (UUTUC) are infrequent and show an occurrence of about 5-10% of all urothelial carcinomas. In this study, we investigated the HER2 status of 171 UUTUC patients with nephroureterectomy. The number of patients is the largest of any HER2 study. All 171 cases were analyzed for both HER2 overexpression using immunohistochemistry and HER2 gene amplification using dual-color in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Neoplasm Recurrence, Local

Share to Proportional Hazards Models

Share to Receptor, ErbB-2

Share to Urologic Neoplasms

Share to Urothelium

Source

Open in PubMed Open full text

Identifiers

PMID: 24551292
PMCID: PMC3925916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.PMID 24551292Read ↗

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese PopulationSemantic proximity Read ↗

HER2 as a target in invasive urothelial carcinoma.Semantic proximity Read ↗

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contextsSemantic proximity Read ↗

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancerSemantic proximity Read ↗

TROP2 expression is associated with early stage and favorable prognosis in Upper tract urothelial carcinomaSemantic proximity Read ↗

Human epidermal growth factor receptor 2 ( HER2 ) gene amplification in non-muscle invasive urothelial bladder cancers: Identification of patients for targeted therapySemantic proximity Read ↗

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma.Semantic proximity Read ↗

Trends of Incidence and Prognosis of Upper Tract Urothelial CarcinomaSemantic proximity Read ↗

The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives.Semantic proximity Read ↗

Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.Semantic proximity Read ↗

STAG2 Coupled With p53 Alteration Has a Significant Impact on Bladder Cancer Recurrence and ProgressionSemantic proximity Read ↗

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary BladderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.